Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. View here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksReact Group Regulatory News (REAT)

Share Price Information for React Group (REAT)

Share Price is delayed by 15 minutes
Get Live Data
44.00    0.00 (0.00%)
Bid:
43.00
Ask:
45.00
Spread: 2.00 (4.651%)
Market Cap: £10.40m
REAT Live PriceLast checked at - London Stock Exchange

Intraday React Group Share Chart

Amendment to Westminster Loan Agreement

20 Dec 2013 14:16

RNS Number : 1372W
Verdes Management PLC
20 December 2013
 



For immediate release: 20 December 2013

Verdes Management PLC

Amendment to Westminster Convertible Loan Agreement

 

 

20 December 2013



 

Verdes Management PLC

Amendment to Westminster Convertible Loan Agreement

 

("Verdes" or the "Company")

 

Further to the announcement dated 5 March 2013 concerning the convertible loan agreement ("Agreement") signed by the Company with Westminster Asset Management Limited ("Westminster"), under which the Company agreed (and has since drawn down) a loan of £125,000 under the Agreement, the Company has agreed with Westminster to make an amendment to the Agreement to set a maximum number of ordinary shares in the Company into which the Loan is able to convert.

 

Under the Agreement the Loan is convertible at 0.055p per ordinary share ("Conversion Price") at the option of Westminster, equating to 227,272,727 ordinary shares. However in the event that theprevailing share price is less than 0.055p at the time of conversion, the Conversion Price will be reduced to be the average of the closing mid-market share price for the 10 business days preceding the date of conversion.

 

The only substantive amendment to the Agreement is that the Conversion Price shall be no lower than 0.05p per new ordinary share, in the event that the 10 day average price falls below 0.05p, which in effect sets the maximum number of shares issuable upon conversion at 250,000,000 new ordinary shares. This term is in line with the Conversion Price under the Newick Convertible Loan (announced on 4 October 2013), the RAB Convertible Loan (announced on 26 November 2013) and the Wildey Convertible Loan (announced on 27 November 2013.)

 

Since Westminster is a related party under the AIM Rules, and the Agreement was originally a related party transaction, the amendments to the Agreement are also classified as a related party transaction. Daan van den Noort, the Company's Chairman is not considered independent, and therefore Sarah Bertolotti and Joep van den Aker ("the Independent Directors") have negotiated and considered the amendments to the Agreement, together with the Company's Nominated Adviser, SPARK Advisory Partners Limited.

 

The Independent Directors, having consulted with the Company's Nominated Adviser, consider the Loan and the terms of the amendment to the Agreement to be fair and reasonable insofar as the Company's shareholders are concerned.

 

All previously announced terms of the Agreement remain the same.

 

For further information, please contact:

 

Verdes Management PLC (Independent Directors)

 

Joep van Den Aker - Non Executive Director +31 6222 476 975

Sarah Bertolotti - Finance Director 07932 569404

 

SPARK Advisory Partners Limited

 

Neil Baldwin 0113 370 8974

Mark Brady 0113 379 8971

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCBSBDDSBDBGXG
Date   Source Headline
17th Jun 202611:56 amRNSDirector/PDMR Shareholding
19th May 202611:23 amRNSInvestor Presentation via Investor Meet Company
19th May 20267:00 amRNSInterim Results and Investor Presentation
13th May 20265:17 pmRNSDirector/PDMR Shareholding
15th Apr 202610:25 amRNSDirector/PDMR Shareholding
31st Mar 20267:28 amRNSAGM Statement
27th Mar 202610:16 amRNSNotice of AGM
13th Feb 20264:22 pmRNSHolding(s) in Company
13th Feb 20264:13 pmRNSHolding(s) in Company
13th Feb 20263:03 pmRNSDirector/PDMR Shareholding
13th Feb 20261:11 pmRNSDirector/PDMR Shareholding
12th Feb 20265:18 pmRNSHolding(s) in Company
12th Feb 202611:35 amRNSHolding(s) in Company
11th Feb 20264:18 pmRNSHolding(s) in Company
10th Feb 20264:33 pmRNSPDMR Dealings
5th Feb 20267:00 amRNSFinal Results
2nd Feb 20267:00 amRNSNotice of Results
19th Jan 20263:37 pmRNSHolding(s) in Company
13th Jan 20262:56 pmRNSDirector/PDMR Shareholding
9th Jan 20263:03 pmRNSHolding(s) in Company
2nd Jan 202611:15 amRNSDirector/PDMR Shareholding
15th Dec 20254:28 pmRNSDirector/PDMR Shareholding
14th Nov 20253:43 pmRNSHolding(s) in Company
28th Oct 20257:00 amRNSTrading Update
16th Oct 20255:18 pmRNSDirector/PDMR Shareholding
16th Sep 20259:13 amRNSDirector/PDMR Shareholding
14th Aug 202511:31 amRNSDirector/PDMR Shareholding
7th Aug 20257:00 amRNSContract Wins
16th Jul 20252:38 pmRNSShare Incentive Plan
15th Jul 20251:53 pmRNSHolding(s) in Company
27th May 20257:00 amRNSInterim Results & Trading Update
19th May 20258:27 amRNSHolding(s) in Company
29th Apr 202512:30 pmRNSHolding(s) in Company
25th Apr 20252:35 pmRNSHolding(s) in Company
27th Mar 20251:15 pmRNSResult of AGM
27th Mar 20257:00 amRNSAGM Statement
19th Mar 20253:01 pmRNSDirector/PDMR Shareholding
19th Mar 20251:15 pmRNSHolding(s) in Company
6th Mar 202512:09 pmRNSDirector/PDMR Shareholding
5th Mar 20257:00 amRNSNotice of AGM
12th Feb 20253:34 pmRNSDirector/PDMR Shareholding
4th Feb 20257:00 amRNS-RContract Win
30th Jan 20251:59 pmRNSHolding(s) in Company
29th Jan 202511:11 amRNSInvestor Presentation
29th Jan 20257:00 amRNSFinal Results
28th Jan 20256:07 pmRNSHolding(s) in Company
21st Jan 20252:00 pmRNSHolding(s) in Company
8th Nov 20245:12 pmRNSHolding(s) in Company
6th Nov 20247:00 amRNSExercise of Options & Total Voting Rights
30th Oct 20243:09 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.